Drug Shortage Report for 5% DEXTROSE INJECTION, USP
Report ID | 150511 |
Drug Identification Number | 00060348 |
Brand name | 5% DEXTROSE INJECTION, USP |
Common or Proper name | 5% DEXTROSE INJECTION, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100 mL (JB0041P) |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-12-06 |
Actual start date | 2021-12-06 |
Estimated end date | 2022-09-01 |
Actual end date | 2022-09-01 |
Shortage status | Resolved |
Updated date | 2022-09-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2022-08-23 | French | Compare |
v22 | 2022-09-01 | English | Compare |
v23 | 2022-09-01 | French | Compare |
v24 | 2022-09-02 | English | Compare |